Login / Signup

Effectiveness of benzbromarone versus febuxostat in gouty patients: a retrospective study.

Dong-Mei LiuBinbin ZhouZhen LiZhuojun ZhangXiaojuan DaiZongfei JiHuiyong ChenYing SunLin-di Jiang
Published in: Clinical rheumatology (2022)
. • Febuxostat had a renal protective effect after about 1 month treatment.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • randomized controlled trial
  • chronic kidney disease
  • newly diagnosed
  • systematic review
  • prognostic factors
  • combination therapy
  • smoking cessation